Bicocca Open Archive

Logo unimib boa
DELL'ORO, RAFFAELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.664
AS - Asia 10.201
EU - Europa 7.184
SA - Sud America 1.482
Continente sconosciuto - Info sul continente non disponibili 601
AF - Africa 253
OC - Oceania 25
Totale 38.410
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.738
SG - Singapore 3.633
CN - Cina 2.104
IT - Italia 1.778
VN - Vietnam 1.622
HK - Hong Kong 1.282
RU - Federazione Russa 1.198
BR - Brasile 1.132
DE - Germania 926
SE - Svezia 865
CA - Canada 752
IE - Irlanda 641
UA - Ucraina 402
GB - Regno Unito 363
FR - Francia 316
IN - India 286
BD - Bangladesh 275
KR - Corea 208
FI - Finlandia 175
AT - Austria 123
AR - Argentina 113
IQ - Iraq 109
ID - Indonesia 98
TR - Turchia 91
ZA - Sudafrica 86
MX - Messico 77
PK - Pakistan 74
PL - Polonia 65
JP - Giappone 64
NL - Olanda 63
EC - Ecuador 62
SA - Arabia Saudita 55
PH - Filippine 52
CO - Colombia 50
ES - Italia 47
VE - Venezuela 45
UZ - Uzbekistan 43
DK - Danimarca 40
MY - Malesia 33
KE - Kenya 32
BE - Belgio 30
CL - Cile 26
TN - Tunisia 26
AU - Australia 25
MA - Marocco 23
PY - Paraguay 21
CZ - Repubblica Ceca 20
EG - Egitto 20
JO - Giordania 19
JM - Giamaica 18
AE - Emirati Arabi Uniti 16
BG - Bulgaria 16
CR - Costa Rica 16
ET - Etiopia 16
PE - Perù 16
CH - Svizzera 14
LT - Lituania 14
RO - Romania 14
HN - Honduras 13
AZ - Azerbaigian 12
LB - Libano 11
AL - Albania 10
IR - Iran 10
KZ - Kazakistan 10
DZ - Algeria 9
EE - Estonia 9
LK - Sri Lanka 9
NI - Nicaragua 9
NP - Nepal 9
PS - Palestinian Territory 9
PT - Portogallo 9
TH - Thailandia 9
BY - Bielorussia 8
IL - Israele 8
UY - Uruguay 8
BH - Bahrain 7
BO - Bolivia 7
CI - Costa d'Avorio 7
DO - Repubblica Dominicana 7
EU - Europa 7
OM - Oman 7
RS - Serbia 7
PA - Panama 6
QA - Qatar 6
SN - Senegal 6
TT - Trinidad e Tobago 6
AM - Armenia 5
AO - Angola 5
HR - Croazia 5
HU - Ungheria 5
SV - El Salvador 5
TW - Taiwan 5
BA - Bosnia-Erzegovina 4
GR - Grecia 4
NG - Nigeria 4
SY - Repubblica araba siriana 4
BB - Barbados 3
GE - Georgia 3
GT - Guatemala 3
KG - Kirghizistan 3
Totale 37.761
Salva come PNG Salva come JPEG
Città #
Singapore 2.023
Ann Arbor 1.870
Ashburn 1.801
Hong Kong 1.259
San Jose 1.191
Fairfield 898
Woodbridge 884
Houston 635
Dublin 614
Milan 589
Chandler 587
Frankfurt am Main 569
Toronto 545
Wilmington 479
New York 471
Ho Chi Minh City 443
Hanoi 415
Jacksonville 408
Hefei 405
Dallas 397
Seattle 366
Santa Clara 346
Beijing 318
Los Angeles 308
Chicago 293
Council Bluffs 289
Dearborn 268
Cambridge 236
Princeton 214
Seoul 202
The Dalles 201
Rome 158
Boardman 146
Lauterbourg 138
Moscow 128
Buffalo 108
Nanjing 108
São Paulo 108
Lawrence 105
Shanghai 103
Vienna 102
Altamura 94
Phoenix 93
Atlanta 87
Da Nang 85
Orem 74
Columbus 73
Munich 73
Helsinki 66
Haiphong 63
Lachine 63
San Diego 62
Brooklyn 60
Jakarta 57
London 56
Denver 54
Guangzhou 53
Chennai 51
Montreal 51
Baghdad 49
San Francisco 49
Lissone 47
Warsaw 45
Rio de Janeiro 42
Nanchang 41
Dong Ket 40
Tokyo 38
Johannesburg 36
Tashkent 36
Changsha 35
Andover 32
Turku 32
Düsseldorf 31
Salt Lake City 31
Shenyang 31
Hebei 30
Nuremberg 30
Turin 30
Belo Horizonte 28
Mumbai 28
Tianjin 28
Boston 27
Dhaka 27
Fremont 27
Figino 26
Brussels 25
Quito 25
Falls Church 24
Hải Dương 24
Hangzhou 23
Miami 23
Zhengzhou 22
Brasília 21
Ha Long 21
Jiaxing 21
Jinan 21
Kunming 21
Philadelphia 21
Poplar 21
Riyadh 21
Totale 23.173
Salva come PNG Salva come JPEG
Nome #
Diagnostic and Therapeutic Approach to Different Hypertensive Phenotypes According to the 2023 ESH Guidelines 769
Autonomic Cardiovascular Alterations in Chronic Kidney Disease: Effects of Dialysis, Kidney Transplantation, and Renal Denervation 625
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 510
Baroreceptors as a target of device-based neuromodulation in heart failure: Long-term outcomes 486
Contrasting effects of carotid baroreceptor stimulation on regional sympathetic drive in chronic human heart failure 462
Heart rate as a sympathetic marker during acute adrenergic challenge 452
Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome. 362
Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values 354
Sympathetic Neural Overdrive in the Obese and Overweight State: Meta-Analysis of Published Studies 353
Alterations in sympathetic nerve traffic in genetic haemochromatosis before and after iron depletion therapy: A microneurographic study 345
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 340
Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: Characteristics and mechanisms 328
Regional differences in sympathetic activation in lean and obese normotensive individuals with obstructive sleep apnoea 326
Neurogenic abnormalities in masked hypertension 318
Prevalence of cardiovascular risk factors in an unselected Italian population. Results of the CardioLab Project 2004-2008 318
It is never too late for a genetic disease: a case of a 79-year-old man with persistent hypokalemia 318
Patterns of regional sympathetic nerve traffic in preascitic and ascitic cirrhosis 318
Severe systemic cytomegalovirus infection in an immunocompetent patient outside the intensive care unit: a case report 309
Structural alterations of the retinal microcirculation in the "prehypertensive" high-normal blood pressure state 305
Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome 304
Long-term sympathoinhibitory effects of surgically induced weight loss in severe obese patients 304
Sympathetic and baroreflex abnormalities in the uncomplicated prediabetic state 304
Sympathetic nerve traffic and baroreflex function in optimal, normal, and high-normal blood pressure states 303
Threshold and Target for Blood Pressure Lowering in the Elderly 298
Cardiac, neuroadrenergic, and portal hemodynamic effects of prolonged aldosterone blockade in postviral child a cirrhosis 297
Short- and long-term neuroadrenergic effects of moderate dietary sodium restriction in essential hypertension 297
Sympathetic overdrive in the metabolic syndrome: meta-analysis of published studies 297
Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study 297
Role of ambulatory blood pressure monitoring in resistant hypertension 294
Extreme dipping: Always means nocturnal hypotension? 294
Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives 293
Reproducibility patterns of plasma norepinephrine and muscle sympathetic nerve traffic in human obesity 292
DIFFERING EFFECTS OF RENAL DENERVATION ON BLOOD PRESSURE AND SYMPATHETIC NERVE TRAFFIC: A SYSTEMATIC REVIEW AND META-ANALYSIS 287
Angiotensin-sympathetic system interactions in cardiovascular and metabolic disease 287
Structural and functional alterations of subcutaneous small resistance arteries in severe human obesity 284
Relationship among morning blood pressure surge, 24-hour blood pressure variability, and cardiovascular outcomes in a white population 283
Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years 282
Sustained sympathoinhibitory effects of cardiac resynchronization therapy in severe heart failure 279
New onset left atrial dilatation in the general population: A quarter-century follow-up 275
Adrenergic and reflex abnormalities in obesity-related hypertension 275
Multicenter Randomized Double-Blind Comparison of Nebivolol plus HCTZ and Irbesartan plus HCTZ in the Treatment of Isolated Systolic Hypertension in Elderly Patients: Results of the NEHIS Study 274
Effects of acute carotid baroreceptor stimulation on sympathetic nerve traffic in resistant and uncontrolled hypertension: a systematic review and meta-analysis 271
Sympathetic and reflex alterations in systo-diastolic and systolic hypertension of the elderly 271
Long-term Saxagliptin Treatment Improves Endothelial Function but not Pulse Wave Velocity and Intima-Media Thickness in Type 2 Diabetic Patients 271
Association Between Arterial Stiffness, High Blood Pressure, and Hypertensive Phenotypes: Insights from the PAMELA Study 269
Prognostic value of serum uric acid: new-onset in and out-of-office hypertension and long-term mortality 265
Effects of hypertension and obesity on the sympathetic activation of heart failure patients 263
Cardiovascular risk and adrenergic overdrive in the metabolic syndrome 263
Different neuroadrenergic activation and baroreflex function in resistant and pseudoresistant hypertension: a microneurographic study 263
IMPACT OF SEASONAL BLOOD PRESSURE CHANGES ON VISIT-TO-VISIT BLOOD PRESSURE VARIABILITY 262
Multicentre randomised, double blind, evaluation of nebivolol plus HCTZ and irbesartan plus HCTZ in the treatment of systolic hypertension in the elderly: the NEHIS Study 261
Sympathetic neural abnormalities in type 1 and type 2 diabetes: a systematic review and meta-analysis 261
SYMPATHETIC OVERDRIVE IN THE RESISTANT HYPERTENSIVE PHENOTYPE 261
Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction 260
FAILURE OF ANTIHYPERTENSIVE TREATMENT TO RESTORE NORMAL SYMPATHETIC ACTIVITY 258
Total cardiovascular risk, blood pressure variability and adrenergic overdrive in hypertension: evidence, mechanisms and clinical implications 257
Triglyceride-glucose Index and Mortality in a Large Regional-based Italian Database (Urrah Project) 255
Diurnal blood pressure variation and sympathetic activity 255
Sympathetic nerve traffic, insulin resistance and baroreflex control of circulation in patients with resistant hypertension 251
Comparison of electrocardiographic versus echocardiographic detection of left ventricular mass changes over time and evaluation of new onset left ventricular hypertrophy 249
Response to possible difference in the sympathetic activation on extreme dippers with or without exaggerated morining surge 248
Comparison between visit-to-visit office and 24-h blood pressure variability in treated hypertensive patients 248
Early sympathetic activation in the initial clinical stages of chronic renal failure 246
Coffee consumption, clinic, 24-hour and home blood pressure. Findings from the PAMELA study 242
Sympathetic Nerve Traffic and Arterial Baroreflex Function in Apparent Drug-Resistant Hypertension 242
Predictive value of different indices of blood pressure variability on 240
Long-term increase in serum uric acid and its predictors over a 25 year follow-up: Results of the PAMELA study 237
The "J curve" problem revisited: old and new findings 233
Restoration of normal sympathetic neural function in heart failure following baroreflex activation therapy: final 43-month study report 233
Sympathetic neural overdrive in congestive heart failure and its correlates: systematic reviews and meta-analysis 233
Primary and secondary prevention of stroke by antihypertensive treatment in clinical trials 231
Reduced Insulin Sensitivity is Associated with Adrenergic Overdrive Independently on Obesity and Hypertension 231
Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity 229
Habitual Regular Coffee Consumption And Arterial Stiffness -Data From The 3rd Pamela Survey 228
Novel Antihypertensive Therapies: Renal Sympathetic Nerve Ablation and Carotid Baroreceptor Stimulation 226
Pheochromocytoma as a Clinical Model of Peripheral Sympathetic Overdrive: Old and New Findings 225
Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: Results of the CROSS study 224
Left ventricular hypertrophy in isolated and dual masked hypertension 224
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project 224
White-Coat Hypertension Without Organ Damage: Impact on Long-Term Mortality, New Hypertension, and New Organ Damage 224
Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensives 221
Prevalence, Awareness And Treatment Of Cardiovascular Risk Factors In Health Professionals In The Cardiovascular Field: The Protecto Esh-Siia Study 220
Prognostic Value and Relative Cutoffs of Triglycerides Predicting Cardiovascular Outcome in a Large Regional‐Based Italian Database 220
Baroreflex activation therapy systems: current status and future prospects 220
Clinical correlates and subclinical cardiac organ damage in different extreme dipping patterns 220
Muscle and skin sympathetic nerve traffic during physician and nurse blood pressure measurement 216
The neglected role of the electrocardiogram in the diagnostic work-up of hypertensive patients: a study in clinical practice 213
Effects of Renal Denervation on Sympathetic Nerve Traffic and Correlates in Drug-Resistant and Uncontrolled Hypertension: A Systematic Review and Meta-Analysis 211
Sympathetic activation in congestive heart failure: Evidence, consequences and therapeutic implications 211
Cardio-Ankle Vascular Index As A Marker Of Left Ventricular Hypertrophy In Treated Hypertensives: Findings From The Pamela Study 210
How to assess sympathetic nervous system activity in clinical practice 210
High heart rate amplifies the risk of cardiovascular mortality associated with elevated uric acid 209
Serum Uric Acid, Hypertriglyceridemia, and Carotid Plaques: A Sub-Analysis of the URic Acid Right for Heart Health (URRAH) Study 207
Sympathetic and baroreflex function in hypertensive or heart failure patients with ventricular arrhythmias 206
Serum Uric Acid/Serum Creatinine Ratio and Cardiovascular Mortality in Diabetic Individuals—The Uric Acid Right for Heart Health (URRAH) Project 205
Reduced insulin sensitivity is associated with adrenergic overdrive in hemochromatosis independently on obesity and hypertension 205
Limited reliability of heart rate as a sympathetic marker in chronic kidney disease 205
Sympathetic activation in obesity: a noninnocent bystander 204
Blood pressure control and antihypertensive treatment 204
Salt intake and sympathetic activity - Response 204
Totale 27.853
Salva come PNG Salva come JPEG
Categoria #
all - tutte 126.490
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 126.490
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.193 0 0 0 183 138 128 71 68 95 110 163 237
2022/20232.510 270 708 231 253 150 408 41 155 140 34 80 40
2023/20242.062 51 54 89 112 285 491 388 61 224 39 41 227
2024/20255.787 329 665 231 251 467 161 288 280 536 852 710 1.017
2025/202614.707 1.888 1.086 1.158 1.564 1.445 690 1.941 604 1.026 1.191 988 1.126
2026/20273.623 446 924 1.835 418 0 0 0 0 0 0 0 0
Totale 38.410